Financial services provider Silver Falcon plans to acquire biotechnology company HemoGenyx Pharmaceuticals (Hemogenyx Pharma) for £8m ($10.5m).
The transaction will enable the acquirer company to expand its business operations.
Both the acquirer and target companies are based in the UK.
The transaction complements the acquirer company’s existing portfolio.
Both companies involved in the acquisition are based in South Africa.
Chinese biopharmaceutical products provider Boya Bio-pharmaceutical Group (formerly Jiangxi Boya Bio-Pharmaceutical), plans to acquire 82% stake in an undisclosed Chinese pharmaceutical company.
Financial services provider China Huarong Asset Management (formerly China Huarong Asset Management ), has announced the sale of eight million shares representing 1.73% stake in pharmaceutical company Northeast Pharmaceutical Group.
Both companies involved in the transaction are based in China.